Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review

Journal article

M. S. Nanjappa, E. Voyiaziakis, B. Pradhan, S. Mannekote Thippaiah and Srinagesh Mannekote Thippaiah

CNS Spectrums, Vol.27(3)

2022

Metrics

8 Record Views

Title: Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review
Creators: M. S. Nanjappa - Park Nicollet Clinic
E. Voyiaziakis - Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
B. Pradhan - Cooper Medical School of Rowan University
S. Mannekote Thippaiah - Creighton University
Srinagesh Mannekote Thippaiah - Psychiatry
Publication Details: CNS Spectrums, Vol.27(3)
Identifiers: 991006046746002656
Academic Unit: Psychiatry; School of Medicine
Resource Type: Journal article